A microenvironment-adaptive GelMA-ODex@RRHD hydrogel for responsive release of H2S in promoted chronic diabetic wound repair

Chronic diabetic wounds present significant treatment challenges due to their complex microenvironment, often leading to suboptimal healing outcomes. Hydrogen sulfide (H<sub>2</sub>S), a crucial gaseous signaling molecule, has shown great potential in modulating inflammation, oxidative stress and extracellular matrix remodeling, which are essential for effective wound healing. However, conventional H<sub>2</sub>S delivery systems lack the adaptability required to meet the dynamic demands of different healing stages, thereby limiting their therapeutic efficacy. To address this, we developed an injectable, ROS-responsive H<sub>2</sub>S donor system integrated within a gelatin methacryloyl (GelMA) hydrogel matrix, forming a double-network hydrogel (GelMA-ODex@RRHD). The injectability of this hydrogel allows for minimally invasive application, conforming closely to wound contours and ensuring uniform distribution. The incorporation of oxidatively modified dextran derivatives (ODex) not only preserves biocompatibility but also enables the chemical attachment of ROS-responsive H<sub>2</sub>S donors. The GelMA-ODex@RRHD hydrogel releases H<sub>2</sub>S in response to oxidative stress, optimizing the environment for cell growth, modulating macrophage polarization and supporting vascular regeneration. This innovative material effectively suppresses inflammation during the initial phase, promotes tissue regeneration in the proliferative phase and facilitates controlled matrix remodeling in later stages, ultimately enhancing wound closure and functional recovery. The H<sub>2</sub>S released by GelMA-ODex@RRHD not only expedited the process of wound healing but also improved the biomechanical characteristics of newborn skin in diabetic mice, particularly in terms of stiffness and elasticity. This enhancement resulted in the skin quality being more similar to normal skin during the wound healing process. By aligning therapeutic delivery with the natural healing process, this approach offers a promising pathway toward more effective and personalized treatments for chronic diabetic wounds.

Authors

Institutions

Publication Details

Journal
Regenerative Biomaterials
Published
2024-11-23
DOI
https://doi.org/10.1093/rb/rbae134
Citations
13
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
4.25

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A microenvironment-adaptive GelMA-ODex@RRHD hydrogel for responsive release of H2S in promoted chronic diabetic wound repair

Shun Yao, Chao Hu, Zhixian Yuan, Rong Shi et al.
13 citations
Regenerative Biomaterials
Obstructive Sleep Apnea Research
4.25
article

A microenvironment-adaptive GelMA-ODex@RRHD hydrogel for responsive release of H2S in promoted chronic diabetic wound repair

Shun Yao, Chao Hu, Zhixian Yuan, Rong Shi, Bibo Ren, Chuwei Zhang, Jun Deng, Chang Wang, Lu Liu, Wei Zhang, Gaoxing Luo, Dejiang Fan, Lunli Xiang
article en
13 citations

Abstract

Chronic diabetic wounds present significant treatment challenges due to their complex microenvironment, often leading to suboptimal healing outcomes. Hydrogen sulfide (H<sub>2</sub>S), a crucial gaseous signaling molecule, has shown great potential in modulating inflammation, oxidative stress and extracellular matrix remodeling, which are essential for effective wound healing. However, conventional H<sub>2</sub>S delivery systems lack the adaptability required to meet the dynamic demands of different healing stages, thereby limiting their therapeutic efficacy. To address this, we developed an injectable, ROS-responsive H<sub>2</sub>S donor system integrated within a gelatin methacryloyl (GelMA) hydrogel matrix, forming a double-network hydrogel (GelMA-ODex@RRHD). The injectability of this hydrogel allows for minimally invasive application, conforming closely to wound contours and ensuring uniform distribution. The incorporation of oxidatively modified dextran derivatives (ODex) not only preserves biocompatibility but also enables the chemical attachment of ROS-responsive H<sub>2</sub>S donors. The GelMA-ODex@RRHD hydrogel releases H<sub>2</sub>S in response to oxidative stress, optimizing the environment for cell growth, modulating macrophage polarization and supporting vascular regeneration. This innovative material effectively suppresses inflammation during the initial phase, promotes tissue regeneration in the proliferative phase and facilitates controlled matrix remodeling in later stages, ultimately enhancing wound closure and functional recovery. The H<sub>2</sub>S released by GelMA-ODex@RRHD not only expedited the process of wound healing but also improved the biomechanical characteristics of newborn skin in diabetic mice, particularly in terms of stiffness and elasticity. This enhancement resulted in the skin quality being more similar to normal skin during the wound healing process. By aligning therapeutic delivery with the natural healing process, this approach offers a promising pathway toward more effective and personalized treatments for chronic diabetic wounds.

Regenerative BiomaterialsVol. 12
Army Medical University (CN), Nantong University (CN), Affiliated Hospital of Nantong University (CN), Gansu Provincial Hospital (CN), Southwest Hospital (CN)
University of Oxford, National Natural Science Foundation of China, Natural Science Foundation of Chongqing
Good health and well-being
Openalex Percentile: Top 5%
Obstructive Sleep Apnea Research
4.25
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.